Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
11.10
+0.24 (2.21%)
Jul 4, 2025, 2:45 PM CST
SHE:002581 Revenue
Shandong Sinobioway Biomedicine had revenue of 35.33M CNY in the quarter ending March 31, 2025, a decrease of -57.84%. This brings the company's revenue in the last twelve months to 311.93M, down -28.78% year-over-year. In the year 2024, Shandong Sinobioway Biomedicine had annual revenue of 360.41M, down -16.14%.
Revenue (ttm)
311.93M
Revenue Growth
-28.78%
P/S Ratio
23.31
Revenue / Employee
655.32K
Employees
476
Market Cap
7.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 360.41M | -69.39M | -16.14% |
Dec 31, 2023 | 429.79M | 72.71M | 20.36% |
Jan 1, 2023 | 357.08M | -45.63M | -11.33% |
Jan 1, 2022 | 402.71M | 125.88M | 45.47% |
Dec 31, 2020 | 276.83M | -290.81M | -51.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |